DNA Vaccines
Inovio Biomedical to Present New Research and Technology Innovations at Bioelectrochemistry Symposium
Published in Proteomics Weekly, April 16th, 2007
Inovio Biomedical Corp. (AMEX: INO), which is focused on the development of DNA vaccines and a novel solid tumor ablation therapy, announced that its scientists will deliver two presentations at the 19th International Symposium on Bioelectrochemistry in Toulouse, France, April 1-4, 2007. The presentations will cover new developments in Inovio's DNA vaccine and solid tumor therapy programs. Both programs are based on the company's core electroporation technology, which uses electrical pulses to increase cellular uptake of therapeutic drugs and, in the case of gene-based treatments such as DNA vaccines, significantly enhance levels of gene expression and potency.
One...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2007-04-16)
More Articles from Proteomics Weekly
- Breast Cancer
Power3 Medical and NeoGenomics to Form Contract Research Organization - Cancer
NeoGenomics and Power3 Medical Products to Form Joint Venture Contract Research Organization - Diagnostic Assays
Applied Biosystems Reagents Improve Data Quality of Real-Time PCR Applications - DNA Research
Applied DNA Sciences Acquires Applied DNA Sciences Europe Ltd. - DNA Research
Metametrix Introduces the New GI Effects Stool Profiles by DNA Analysis - DNA Vaccines
CytoGenix Announces Successful Testing of synDNA Vaccine for Avian Influenza Virus - More from this issue of Proteomics Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
